Author

Lucy Medcalf 1

1 Kings College Hospital,London,United Kingdom

A Retrospective Real World Analysis of 6-Thioguanine Nucleotide (6-TGN) Monitoring for Azathioprine dosing in Inflammatory Bowel Disease

Jaba Zarkua, Bilal Mateen, Maxel T Romney, Lucy Medcalf, Guy Chung-Faye, Patrick Dubois, Royce P Vincent, Alexandra Kent, Bu'Hussain Hayee

EARLY CHANGE IN FECAL CALPROTECTIN PREDICTS PRIMARY NON- RESPONSE TO ANTI-TNF? THERAPY IN INFLAMMATORY BOWEL DISEASE

Polychronis Pavlidis, Shraddha Gulati, Patrick Dubois, Guy Chung-Faye, Jaroslava Tumova, Lucy Medcalf, Lee Meng Choong, Roy Sherwood, Ingvar Bjarnason, Bu Hayee

FAECAL CALPROTECTIN MEASURED AFTER THE THIRD DOSE OF ANTI-TNFΑ IS AN EARLY AND HIGHLY ACCURATE PREDICTOR OF RESPONSE IN CROHN'S DISEASE

Polychronis Pavlidis, Anna Cavazza, Nabil Siddique, Panagiotis Stamoulos, Nicola Grasso, Jaroslava Tumova, Lucy Medcalf, Guy Chung Faye, Patrick Dubois, Ingvar Bjarnason, Bu'Hussain Hayee

HOME-TESTING OF FAECAL CALPROTECTIN USING THE IBDOC? SYSTEM: A COMPARATIVE PILOT STUDY

Ian Yang Liew, Polychronis Pavlidis, Lucy Medcalf, Lee Meng Choong, Guy Chung-Faye, Patrick Dubois, Roy Sherwood, Bu Hayee

MY IBD CARE, A DIGITAL THERAPEUTIC FOR IBD, IS SAFE AND EFFECTIVE: CASE-CONTROL STUDY IN TWO UK CENTRES

Gareth Parkes, Bu Hayee, Nanna Asgeirsdottir, Nader Alaghband, Ana Ibarra, Anouk Lehmann, Lucy Medcalf

VEDOLIZUMAB: EARLY EXPERIENCE AND MEDIUM-TERM FOLLOW UP DATA FROM TWO UK TERTIARY IBD CENTRES ? A RETROSPECTIVE COHORT STUDY

Mark A Samaan, Polychronis Pavlidis, Emma Johnston, Ben Warner, Jonathan Digby-Bell, Ioannis Koumoutsos, Steven Fong, Rimma Goldberg, Shraddha Gulati, Lucy Medcalf, Marlene Sastrillo, Cordella Brown-Clarke, Johanna Bidewell-Sullivan, Katrina Forsyth, Emma Lee, Anna Stanton, Julie Duncan, Guy Chung-Faye, Patrick Dubois, N

Item 1 - 6 / 6
1